Activation of the mTORC1 complex is a critical step in the progression of cardiac disease after myocardial infarction and pressure overload induced hypertrophy. This fact has spurred interest for ways to therapeutic target the mTORC1 complex in the heart. However, no drugs are currently available that specifically target mTORC1 in cardiomyocytes highlighting the need for the development of new therapeutic regimes. This proposal will inhibit mTORC1 through a novel molecular strategy involving PRAS40, an endogenous mTORC1 inhibitor and substrate. PRAS40 has been identified in the last years as a powerful tool to inhibit cellular growth in cancer cells. A unique molecular feature of PRAS40 is to inhibit mTORC1 and simultaneously increase mTORC2 activation, which increase cellular survival via increased AKT activation. Judicious enhancement of PRAS40 expression will inhibit pathological growth and senescence on the one hand and improve survival on the other hand. Accomplishing the stated aims of this proposal will provide a first comprehensive characterization of PRAS40 in cardiac biology. The innovation of this proposal is based on the first characterization of PRAS40 in the cardiac context and the unique molecular profile of PRAS40. The short- term goal is to delineate the critical importance of PRAS40 in the heart and demonstrate the efficiency of PRAS40 interventional approaches to inhibit pathological growth, blunt cardiac senescence and improve insulin signaling.
Specific aims are: 1) Pathological cardiac growth and senescence are inhibited by PRAS40, 2) cell survival and insulin signaling are improved by PRAS40 and 3) that mTORC1 inhibition together with mTORC2 activation by PRAS40 is protective against pathological damage. The significance of these studies is to define ways to blunt hyperactivation of mTORC1 in cardiac diseases with the goal to delineate new therapeutic ways to target mTORC1 in the heart. Collectively, the studies in this proposal will pave the way for interventional approaches to regulate PRAS40 activity in service to block pathological growth and senescence and improving AKT dependent signaling.
Heart disease, especially heart failure, is a major public health issue in the United States placing a considerable burden upon our health care system. Despite recent progress in understanding pathophysiology, heart failure still carries a 5-year mortality that rivals most cancers. This proposal focuses upon a novel fundamental molecular mechanism involving inhibition of pathological growth and blunting of senescence together with improving survival to maintain cardiac structure and function after myocardial infarction or pressure overload.
|Broughton, Kathleen M; Sussman, Mark A (2016) Empowering Adult Stem Cells for Myocardial Regeneration V2.0: Success in Small Steps. Circ Res 118:867-80|
|Hariharan, Nirmala; Sussman, Mark A (2015) Cardiac aging - Getting to the stem of the problem. J Mol Cell Cardiol 83:32-6|
|Nguyen, Nathalie; Sussman, Mark A (2015) Rejuvenating the senescent heart. Curr Opin Cardiol 30:235-9|
|Hariharan, Nirmala; Quijada, Pearl; Mohsin, Sadia et al. (2015) Nucleostemin rejuvenates cardiac progenitor cells and antagonizes myocardial aging. J Am Coll Cardiol 65:133-47|
|Quijada, Pearl; Sussman, Mark A (2015) Circulating around the tissue: hematopoietic cell-based fusion versus transdifferentiation. Circ Res 116:563-5|
|Quijada, Pearl; Hariharan, Nirmala; Cubillo, Jonathan D et al. (2015) Nuclear Calcium/Calmodulin-dependent Protein Kinase II Signaling Enhances Cardiac Progenitor Cell Survival and Cardiac Lineage Commitment. J Biol Chem 290:25411-26|
|Samse, Kaitlen; Emathinger, Jacqueline; Hariharan, Nirmala et al. (2015) Functional Effect of Pim1 Depends upon Intracellular Localization in Human Cardiac Progenitor Cells. J Biol Chem 290:13935-47|
|Gude, Natalie; Joyo, Eri; Toko, Haruhiro et al. (2015) Notch activation enhances lineage commitment and protective signaling in cardiac progenitor cells. Basic Res Cardiol 110:29|
|Doroudgar, Shirin; VÃ¶lkers, Mirko; Thuerauf, Donna J et al. (2015) Hrd1 and ER-Associated Protein Degradation, ERAD, are Critical Elements of the Adaptive ER Stress Response in Cardiac Myocytes. Circ Res 117:536-46|
|Quijada, Pearl; Salunga, Hazel T; Hariharan, Nirmala et al. (2015) Cardiac Stem Cell Hybrids Enhance Myocardial Repair. Circ Res 117:695-706|
Showing the most recent 10 out of 36 publications